ClinicalTrials.govpublic full text
TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors
hiv infections, hiv-1, antiretroviral, aids, tmc278-c215, tmc278-tidp6-c215, treatment naive, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 824809
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.